SARAH WOODFIELD to Pyrimidines
This is a "connection" page, showing publications SARAH WOODFIELD has written about Pyrimidines.
Connection Strength
0.274
-
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
Score: 0.183
-
The novel kinase inhibitor EMD1214063 is effective against neuroblastoma. Invest New Drugs. 2014 Oct; 32(5):815-24.
Score: 0.090